Literature DB >> 23701157

Prognostic factors for stage IV gastric cancer.

Hiroyuki Baba1, Koki Kuwabara, Toru Ishiguro, Kensuke Kumamoto, Yoichi Kumagai, Keiichiro Ishibashi, Norihiro Haga, Hideyuki Ishida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23701157      PMCID： PMC3723175          DOI： 10.9738/INTSURG-D-12-00027.1

Source DB:  PubMed          Journal:  Int Surg        ISSN： 0020-8868


× No keyword cloud information.
  29 in total

1.  Prognosis of patients after palliative surgical procedures for carcinoma of the stomach.

Authors:  F Bozzetti; G Bonfanti; R A Audisio; R Doci; G Dossena; L Gennari; S Andreola
Journal:  Surg Gynecol Obstet       Date:  1987-02

2.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002).

Authors:  Hiroya Takiuchi; Hiroyuki Narahara; Toshimasa Tsujinaka; Masahiro Gotoh; Sei-ichiro Kawabe; Ken-ichi Katsu; Hiroyasu Iishi; Masaharu Tatsuta; Kazumasa Fujitani; Hiroshi Furukawa; Tetsuo Taguchi
Journal:  Jpn J Clin Oncol       Date:  2005-09-01       Impact factor: 3.019

5.  Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer.

Authors:  Takahiro Tsushima; Shuichi Hironaka; Narikazu Boku; Nozomu Machida; Kentaro Yamazaki; Hirofumi Yasui; Keisei Taku; Akira Fukutomi; Yusuke Onozawa
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

6.  Tumor load and surgical palliation in gastric cancer.

Authors:  J J Bonenkamp; M Sasako; J Hermans; C J van de Velde
Journal:  Hepatogastroenterology       Date:  2001 Sep-Oct

7.  Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.

Authors:  Takahiro Tsushima; Shuichi Hironaka; Narikazu Boku; Nozomu Machida; Kentaro Yamazaki; Hirofumi Yasui; Akira Fukutomi; Akiko Todaka; Hiroya Taniguchi; Yusuke Onozawa; Keisei Taku
Journal:  Int J Clin Oncol       Date:  2011-10-22       Impact factor: 3.402

8.  Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer.

Authors:  Kazumasa Fujitani; Hiroyuki Narahara; Hiroya Takiuchi; Toshimasa Tsujinaka; Eriko Satomi; Masahiro Gotoh; Motohiro Hirao; Hiroshi Furukawa; Tetsuo Taguchi
Journal:  Oncology       Date:  2005-11-25       Impact factor: 2.935

9.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

10.  Value of palliative resection in gastric cancer.

Authors:  H H Hartgrink; H Putter; E Klein Kranenbarg; J J Bonenkamp; C J H van de Velde
Journal:  Br J Surg       Date:  2002-11       Impact factor: 6.939
View more
  6 in total

1.  Correlations of MMP-2 and TIMP-2 gene polymorphisms with the risk and prognosis of gastric cancer.

Authors:  De-Yong Zhang; Jing Wang; Guan-Qi Zhang; Xian-Qun Chu; Jian-Liang Zhang; Yong Zhou
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Prognostic role of gastrectomy in patients with gastric cancer with positive peritoneal cytology.

Authors:  Okihide Suzuki; Minoru Fukuchi; Erito Mochiki; Toru Ishiguro; Jun Sobajima; Hisashi Onozawa; Hideko Imaizumi; Youichi Kumagai; Hiroyuki Baba; Kensuke Kumamoto; Yoshitaka Tsuji; Keiichiro Ishibashi; Hideyuki Ishida
Journal:  Int Surg       Date:  2014 Nov-Dec

3.  Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India

Authors:  Asmanaz Saleem Nadaf; Hephzibah Rani; Udipi Shastri Dinesh
Journal:  Asian Pac J Cancer Prev       Date:  2018-05-26

4.  The Diagnostic and Prognostic Value of miR-200c in Gastric Cancer: A Meta-Analysis.

Authors:  Zong-Sheng Huang; Xian-Wen Guo; Guo Zhang; Lie-Xin Liang; Bing Nong
Journal:  Dis Markers       Date:  2019-04-04       Impact factor: 3.434

5.  Targeting kinesin family member 21B by miR-132-3p represses cell proliferation, migration and invasion in gastric cancer.

Authors:  Bingtian Liu; Ling Qiang; Bingxin Guan; Zhipeng Ji
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  Deep learning-based virtual cytokeratin staining of gastric carcinomas to measure tumor-stroma ratio.

Authors:  Yiyu Hong; You Jeong Heo; Binnari Kim; Donghwan Lee; Soomin Ahn; Sang Yun Ha; Insuk Sohn; Kyoung-Mee Kim
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.